{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:36:22Z","timestamp":1753893382798,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to describe a case of glomerulosclerosis resulting in nephrotic syndrome following the administration of pamidronate disodium to treat clinical calcitriol toxicity in a dog.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>A 12-week-old intact male Labrador Retriever weighing 11.8 kg presented with lethargy and vomiting for 20 h after ingesting a 100 g tube of topical antipsoriatic cream (3 mcg\/g of calcitriol; Vectical Ointment\u2122, Galderma, Lausanne, Switzerland). Severe hypercalcemia was present on the day of the presentation. Hypercalcemia treatments such as saline diuresis, furosemide (Salix<jats:sup>\u00ae<\/jats:sup>, furosemide, Merck Animal Health, Kenilworth, NJ), and dexamethasone sodium phosphate (Dexamethasone SP, Mylan, Canonsburg, PA) were initiated. The dog was also administered a single dose of pamidronate disodium (Pamidronate disodium, Mylan, Canonsburg, PA) on the day of presentation. Initially, the patient's clinical signs improved, and the hypercalcemia resolved. Exactly 130 h post-pamidronate disodium (Dexamethasone SP, Mylan, Canonsburg, PA) administration, the patient developed biochemical abnormalities and severe edema, consistent with nephrotic syndrome, and was euthanized. Necropsy results revealed evidence of focal segmental glomerulosclerosis (FSGS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Unique information<\/jats:title><jats:p>Pamidronate disodium, commonly used for the treatment of hypercalcemia, may have resulted in glomerulosclerosis and nephrotic syndrome in a dog with calcitriol toxicity. This complication should be taken into consideration when monitoring patients treated with pamidronate disodium for hypercalcemia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fvets.2022.956153","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:52:51Z","timestamp":1660287171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Focal segmental glomerulosclerosis and nephrotic syndrome following treatment with pamidronate for calcitriol toxicity"],"prefix":"10.3389","volume":"9","author":[{"given":"Katherine Ann","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Blong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/ced.14499","article-title":"Prevalence of vitamin D analogue toxicity in dogs","volume":"46","author":"Ho","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0195-5616(89)50030-5","article-title":"Hypercalcemia","volume":"19","author":"Chew","year":"1989","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"B3","unstructured":"VECTICAL (calcitriol), ointment, for topical, use"},{"key":"B4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0019-5154.127668","article-title":"Immunomodulatory mechanisms of action of calcitriol in psoriasis","volume":"59","author":"Raychaudhuri","year":"2014","journal-title":"Indian J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.tcam.2013.03.006","article-title":"Cholecalciferol","volume":"28","author":"Peterson","year":"2013","journal-title":"Top Companion Anim Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1939-1676.2005.tb02654.x","article-title":"Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia","volume":"19","author":"Hostutler","year":"2005","journal-title":"J Vet Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1435-6935.2002.00022.x","article-title":"Calcipotriene toxicosis in a dog successfully treated with Pamidronate Disodium","volume":"12","author":"Pesillo","year":"2002","journal-title":"J Vet Emerg Crit Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1939-1676.2005.tb02661.x","article-title":"Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement","volume":"19","author":"Fan","year":"2005","journal-title":"J Vet Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0378-4274(98)80335-4","article-title":"Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs","volume":"60","author":"Rumbeiha","year":"1999","journal-title":"Am J Vet Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2460\/ajvr.2000.61.9","article-title":"Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs","volume":"61","author":"Rumbeiha","year":"2000","journal-title":"Am J Vet Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/vco.12191","article-title":"Extravasation reactions associated with the administration of pamidronate: 11 cases (2008-2013)","volume":"15","author":"Marker","year":"2017","journal-title":"Vet Comp Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5326\/0400075","article-title":"Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy","volume":"40","author":"Kadar","year":"2004","journal-title":"J Am Anim Hosp Assoc."},{"key":"B13","unstructured":"Pamidronate [Updated 2021 Jun 29]\n            BallardT\n            CharguiS\n          Treasure Island, FLStatPearls PublishingStatPearls2022"},{"key":"B14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5414\/CNP61063","article-title":"Pamidronate-induced nephrotoxic tubular necrosis\u2013a case report","volume":"61","author":"Smetana","year":"2004","journal-title":"Clin Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1016\/S0272-6386(03)00214-2","article-title":"Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity","volume":"41","author":"Banerjee","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s12032-010-9628-7","article-title":"Wetzels JF. Nephrotic syndrome induced by pamidronate","volume":"28","author":"Dam","year":"2011","journal-title":"Med Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"647846","DOI":"10.3389\/fvets.2021.647846","article-title":"Retrospective evaluation of acute kidney injury after zoledronic acid administration to dogs with malignant osteolysis","volume":"8","author":"Vidal","year":"2021","journal-title":"Front Vet Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cvsm.2018.06.006","article-title":"Common rodenticide toxicoses in small animals","volume":"48","author":"DeClementi","year":"2018","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"B20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bone.2010.12.024","article-title":"The kidney and bisphosphonates","volume":"49","author":"Miller","year":"2011","journal-title":"Bone."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.956153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:52:56Z","timestamp":1660287176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.956153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":20,"alternative-id":["10.3389\/fvets.2022.956153"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.956153","relation":{},"ISSN":["2297-1769"],"issn-type":[{"type":"electronic","value":"2297-1769"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"article-number":"956153"}}